Psychopharmacological treatment for cognitive impairment in survivors of traumatic brain injury: A critical review

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 21, Issue 4, 2009, Pages 362-370

  Writer, Brian W ^a   Schillerstrom, Jason E ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; CARBAMAZEPINE; CARBIDOPA; CENTRAL STIMULANT AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; GALANTAMINE; LEVODOPA; LITHIUM; METHYLPHENIDATE; MILNACIPRAN; MOOD STABILIZER; NEUROLEPTIC AGENT; NORTRIPTYLINE; PRAMIPEXOLE; PSYCHOTROPIC AGENT; QUETIAPINE; RIVASTIGMINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANQUILIZER; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID;

CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; HUMAN; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; SURVIVOR; TRAUMATIC BRAIN INJURY; UNSPECIFIED SIDE EFFECT;

EID: 73549094266     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2009.21.4.362     Document Type: Review

References (53)

1. Powell JM, Ferraro JV, Dikmen SS, et al: Accuracy of mild traumatic brain injury diagnosis. Arch Phys Med Rehabil 2008; 89:1550-1555
2. Langlois JA, Ruthland-Brown W, et al: The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 2006; 21:375-378
3. Kaufman DM: Clinical Neurology for Psychiatrists, 6th ed. Philadelphia, Saunders Elsevier, 2007, pp 537-548
4. Warden DL, Gordon B, McAllister TW, et al: Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J Neurotrauma 2006; 23:1468-1501
5. Kim E, Lauterbach EC, Reeve A, et al: Neuropsychiatric complications of traumatic brain injury: a critical review of the literature (a report by the ANPA Committee on Research). J Neuropsychiatry Clin Neurosci 2007; 19:106-127
6. Centers for Disease Control (CDC) and Prevention: Facts About Traumatic Brain Injury. Available at http://www.dvbic.org/TBI---The-Military/TBI-Facts. aspx
7. Defense and Veterans Brain Injury Center (DVBIC): Facts About Traumatic Brain Injury. Available at http://dvbic.org/index.html
8. National Institute of Health National Institute of Neurological Disorders and Stroke Publication No. 02-2478. Traumatic Brain Injury: Hope Through Research 2002. Available at www.ninds.nih.gov/disorders/tbi/tbi-htr.pdf
9. Sadock BJ, Sadock VA: Kaplan & Sadock's Synopsis of Psychiatry Behavioral Sciences/Clinical Psychiatry, 10th ed. Philadelphia, Lippincott Williams & Wilkins, 2007, pp 363-364
10. Stern TA, Rosenbaum JF, Fava M, et al: Massachusetts General Hospital Comprehensive Clinical Psychiatry. Philadelphia, Mosby Elsevier, 2008, pp 1107-1121
11. Rao V, Lyketsos C: Neuropsychiatric sequelae of traumatic brain injury. Psychosomatics 2000; 41:95-103
12. Lee HB, Lyketsos CG, Rao V: Pharmacological management of the psychiatric aspects of traumatic brain injury. Int Rev Psychiatry 2003; 15:359-370
13. Rapoport MJ, McCullagh S, Shammi P, et al: Cognitive impairment associated with major depression following mild and moderate traumatic brain injury. J Neuropsychiatry Clin Neurosci 2005; 17:61-65
14. Andreoli TE, Carpenter CC, Griggs RC, et al (eds): Cecil Essentials of Medicine, 5th ed. Philadelphia, WB Saunders, 2001, pp 953-955
15. Rassovsky Y, Satz P, Alfano MS, et al: Functional outcome in TBI I: neuropsychological, emotional, and behavioral mediators. J Clin Exp Neuropsychol 2006; 28:567-580
16. Rassovsky Y, Satz P, Alfano MS, et al: Functional outcome in TBI II: verbal memory and information processing speed mediators. J Clin Exp Neuropsychol 2006; 28:581-591
17. Jorge R, Robinson RG: Mood disorders following traumatic brain injury. Int Rev Psychiatry 2003; 15:317-327
18. Lee H, Kim SW, Kim JM, et al: Comparing effects of methylphenidate, sertraline, and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum Psychopharmacol Clin Exp 2005; 20:97-104
19. Gualtieri CT, Evans RW: Stimulant treatment for the neurobehavioral sequelae of traumatic brain injury. Brain Inj 1988; 2:273-290
20. Plenger PM, Dixon CE, Castillo RM, et al: Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil 1996; 77:536-540
21. Whyte J, Hart T, Schuster K, et al: Effects of methylphenidate on attentional function after traumatic brain injury: a randomized, placebo-controlled trial. Am J Phys Med Rehabil 1997; 76:440-450
22. Mahalick DM, Carmel PW, Greenberg JP, et al: Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatr Neurosurg 1998; 29:121-126
23. Whyte J, Hart T, Vaccaro M, et al: Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil 2004; 83:401-420
24. Kim YH, Ko MH, Na SY, et al: Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study. Clin Rehabil 2006; 20:24-30
25. Kaelin DL, Cifu DX, Matthies B: Methylphenidate effect on attention deficit in the acutely brain-injured adult. Arch Phys Med Rehabil 1996; 77:6-9
26. Hornyak JE, Nelson VS, Hurvitz EA: The use of methylphenidate in pediatric traumatic brain injury. Pediatric Rehabilitation 1997;1:15-17
27. Williams SE, Ris MD, Ayyangar R, et al: Recovery in pediatric brain injury: is psychostimulant medication beneficial? J Head Trauma Rehabil 1998; 13:73-81
28. Schneider WN, Drew-Cates J, Wong TM, et al: Cognitive and behavioral efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study. Brain Inj 1999;13:863-872
29. McDowell S, Whyte J, D'Esposito M: Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 1998; 121:1155-1164
30. Meythaler JM, Brunner RC, Johnson A: Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil 2002; 17:300-313
31. Powell JH, Al-Adawi S, Morgan J, et al: Motivational deficits after brain injury: effects of bromocriptine in 11 patients. J Neurol Neurosurg Psychiatry 1996; 60:416-421
32. Patrick PD, Blackman JA, Mabry JL, et al: Dopamine agonist therapy in low-response children following traumatic brain injury. J Child Neurol 2006; 21:879-885
33. Kraus MF, Smith GS, Butters M, et al: Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET). Brain Inj 2005; 19:471-479
34. Beers SR, Skold A, Dixon CE, et al: Neurobehavioral effects of amantadine after pediatric traumatic brain injury: a preliminary report. J Head Trauma Rehabil 2005; 20:450-463
35. Morey CE, Cilo M, Berry J, et al: The effect of Aricept in persons with persistent memory disorder following traumatic brain injury: a pilot study. Brain Inj 2003; 17:809-815
36. Zhang L, Plotkin RC, Wang G, et al: Cholinergic augmentation with donepezil enhances recovery in short term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil 2004; 85:1050-1055
37. Khateb A, Ammann J, Annoni JM, et al: Cognition-enhancing effects of donepezil in traumatic brain injury. Eur Neurol 2005; 54:39-45
38. Kaye NS, Townsend JB, Ivins R: An open-label trial of donepezil (Aricept) in the treatment of persons with mild traumatic brain injury. J Neuropsychiatry Clin Neurosci 2003; 15:383-385
39. Tenovuo O: Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury: clinical experience in 111 patients. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:61-67
40. Meythaler JA, Depalma L, Devivo MJ, et al: Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes. Brain Inj 2001; 15:321-331
41. Horsfield SA, Rosse RB, Tomasino V, et al: Fluoxetine's effects on cognitive performance in patients with traumatic brain injury. Int J Psychiatry Med 2002; 32:337-344
42. Fann JR, Uomoto JM, Katon WJ: Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics 2001; 42:48-54
43. Reinhard DL, Whyte J, Sandel E: Improved arousal and initiation following tricyclic antidepressant use in severe brain injury. Arch Phys Med Rehabil 1996; 77:80-83
44. Kanetani K, Kimura M, Endo S: Therapeutic effects of milnacipran (serotonin noradrenaline reuptake inhibitor) on depression following mild and moderate traumatic brain injury. J Nippon Med School 2003; 70:313-320
45. Wroblewski BA, Joseph AB, Kupfer J, et al: Effectiveness of valproic acid on destructive and aggressive behaviors in patients with acquired brain injury. Brain Inj 1997; 11:37-47
46. Smith KR, Goulding PM, Wilderman D, et al: Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study. Arch Neurology 1994; 51:653-660
47. Dikmen SS, Machamer MA, Winn HR, et al: Neuropsychological effects of valproate in traumatic brain injury. Neurology 2000; 54:895-902
48. Chatham-Showalter PE: Carbamazepine for combativeness in acute traumatic brain injury. J Neuropsychiatry Clin Neurosci 1996; 8:96-99
49. Persinger MA: Subjective improvement following treatment with carbamazepine (Tegretol) for a subpopulation of patients with traumatic brain injuries. Percept Mot Skills 2000; 90:37-40
50. Mysiw WJ, Bogner JA, Corrigan JD, et al: The impact of acute care medications on rehabilitation outcome after traumatic brain injury. Brain Inj 2006; 20:905-911
51. Kim E, Bijlani M: A pilot study of quetiapine treatment of aggression due to traumatic brain injury. J Neuropsychiatry Clin Neurosci 2006; 18:547-549
52. Vink R, Nimmo AJ: Multifunctional drugs for head injury. Neurotherapeutics 2009; 6:28-42
53. Royall DR, Lauterbach EC, Kaufer D, et al: The cognitive correlates of functional status: a review from the committee on research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2007; 19:249-265